Shangfei Luo

机构：Guangzhou University of Chinese Medicine, Shandong University of Traditional Chinese Medicine, First Affiliated Hospital of Guangzhou University of Chinese Medicine

发表论文 17 篇 · 总被引 504 次 · h-index 9

代表论文

• Myeloid Piezo1 Deletion Protects Renal Fibrosis by Restraining Macrophage Infiltration and Activation (2022 · Hypertension · 被引 110)
• Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE-/- mice fed with HFD (2020 · Journal of Ethnopharmacology · 被引 88)
• Inhibition of chemically and mechanically activated Piezo1 channels as a mechanism for ameliorating atherosclerosis with salvianolic acid B (2022 · British Journal of Pharmacology · 被引 80)
• Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice (2023 · Theranostics · 被引 71)
• Guizhitongluo Tablet inhibits atherosclerosis and foam cell formation through regulating Piezo1/NLRP3 mediated macrophage pyroptosis (2024 · Phytomedicine · 被引 39)
• Cardiomyocyte-specific Piezo1 deficiency mitigates ischemia-reperfusion injury by preserving mitochondrial homeostasis (2024 · Redox Biology · 被引 31)